moxifloxacin has been researched along with Ocular Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM | 1 |
| Gade, SK; Garg, P; Nirmal, J; Venuganti, VVK | 1 |
| Al-Dhubiab, BE; Attimarad, M; Gupta, S; Jacob, S; Morsy, MA; Nair, AB; Shah, J; Shinu, P; Sreeharsha, N; Venugopala, KN | 1 |
| Banerjee, P; Biswas, S; Chattopadhyay, C; Das, D; Mondal, KK; Ray, B | 1 |
| Mah, FS | 1 |
| Bolinao, JG; Caparas, VL; Espiritu, CR | 1 |
1 review(s) available for moxifloxacin and Ocular Infections
| Article | Year |
|---|---|
Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.
Topics: Administration, Topical; Aza Compounds; Bacterial Infections; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Quinolines | 2004 |
5 other study(ies) available for moxifloxacin and Ocular Infections
| Article | Year |
|---|---|
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Longitudinal Studies; Moxifloxacin; Ofloxacin; Retrospective Studies | 2022 |
Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
Topics: Contact Lenses; Cornea; Dexamethasone; Drug Delivery Systems; Eye Infections; Humans; Hydrogels; Moxifloxacin | 2020 |
Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Topics: Adhesiveness; Administration, Ophthalmic; Administration, Topical; Animals; Calorimetry, Differential Scanning; Cornea; Drug Compounding; Drug Liberation; Drug Stability; Eye Infections; Gels; Goats; Moxifloxacin; Permeability; Rabbits; Research Design; Rheology; Viscosity | 2021 |
Corneal ulcer with Scopulariopsis brevicaulis and Staphylococcus aureus--a rare case report.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections; Fluoroquinolones; Humans; Male; Moxifloxacin; Natamycin; Quinolines; Scopulariopsis; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Cell Count; Endophthalmitis; Endothelium, Corneal; Eye Infections; Female; Fluoroquinolones; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Visual Acuity | 2007 |